WO2016065684A1 - Method for maintaining bone morphogenetic protein-2 activity under the irradiation sterilization conditions - Google Patents
Method for maintaining bone morphogenetic protein-2 activity under the irradiation sterilization conditions Download PDFInfo
- Publication number
- WO2016065684A1 WO2016065684A1 PCT/CN2014/092094 CN2014092094W WO2016065684A1 WO 2016065684 A1 WO2016065684 A1 WO 2016065684A1 CN 2014092094 W CN2014092094 W CN 2014092094W WO 2016065684 A1 WO2016065684 A1 WO 2016065684A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bmp
- irradiation
- alp
- unirradiated
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
Definitions
- the invention relates to the activity maintenance of the bone morphogenetic protein-2 (BMP-2) in the irradiation sterilization process, the irradiation object is BMP-2, and the irradiation source of 60 Co, 137 Cs, 192 Ir is used, and the irradiation dose is 0.01. -100kGy.
- BMP-2 bone morphogenetic protein-2
- Bone morphogenetic protein is widely used mainly because it induces the formation of bone and cartilage, can be used as a therapeutic agent for the treatment of fractures and periodontal defects, and can induce bone growth around implants and artificial prostheses.
- Traditional gene knockout experiments have shown that bone morphogenetic proteins possess a variety of biological activities, such as early embryogenesis, multi-dimensional organ formation and other functions can be achieved by regulating cell proliferation, differentiation and apoptosis.
- a series of human bone morphogenetic proteins have been shown to stimulate bone formation, and recombinant human bone morphogenetic proteins have also been applied.
- BMP-2 has almost the same bone repairing ability as autologous bone and is considered to have the strongest osteoinductive activity.
- Sterilization is required for the clinical use of BMP-2 and BMP-2 loaded medical devices.
- BMP-2 BMP-2 loaded medical devices.
- Ethylene oxide can chemically react with proteinaceous materials to inactivate BMP-2; autoclaving sterilizes BMP-2 and inactivates it.
- Irradiation sterilization is an effective method for killing microorganisms on most substances by emitting radiation from radioactive materials.
- the temperature is not significantly increased throughout the sterilization process, and it is a good sterilization method for heat sensitive compounds.
- the invention adds the BMP-2 solution into the centrifuge tube, seals it with a sealing film, puts it into a thermos flask, fills it with ice, irradiates with 60 Co, 137 Cs, 192 Ir source rays, and sets the dose to be 0.01-100 kGy.
- the dosage is set to 15-50 kGy; the irradiation process to BMP-2 is achieved.
- the cells were then routinely cultured in DF12 complete medium to establish unirradiated BMP-2.
- the group and irradiated BMP-2 group were tested for ALP content in each well after 7 days of cell culture.
- the activity of BMP-2 was determined by the level of ALP, and the detection of BMP-2 activity was achieved.
- the principle of detecting BMP-2 activity in the present invention is that ALP is an important index for cell differentiation into osteoblasts, BMP-2 activity is high, and the tendency of cells to differentiate into osteoblasts is obvious, and the ALP expression level is high, and the content of ALP can be high or low.
- the level of BMP-2 activity was measured.
- the invention has the advantages that the problem of deactivation in the process of BMP-2 irradiation sterilization is effectively solved, and the application prospect thereof is improved.
- Figure 1 Changes in ALP content in cells after 60 Co-irradiation at 25 kGy;
- Figure 2 Changes in ALP content in cells after 60 CoG irradiation at 50 kGy;
- Figure 3 Changes in ALP content in cells after 60 Co-ray irradiation at 35 kGy.
- Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
- Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
- Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
- Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
- Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
- Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
- Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
- Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
- Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
- Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
- Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
- Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
- Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
- Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
本发明涉及骨形态发生蛋白-2(BMP-2)辐照灭菌过程中的活性保持,其辐照对象为BMP-2,采用60Co、137Cs、192Ir发射源,辐照剂量为0.01-100kGy。The invention relates to the activity maintenance of the bone morphogenetic protein-2 (BMP-2) in the irradiation sterilization process, the irradiation object is BMP-2, and the irradiation source of 60 Co, 137 Cs, 192 Ir is used, and the irradiation dose is 0.01. -100kGy.
骨形态发生蛋白(BMP)被广泛应用,主要是因为它可以诱导骨和软骨的形成,可作为治疗骨折和牙周缺陷的治疗剂,并能够在植入物和人工假体周围诱导骨生长。传统的基因剔除实验表明,骨形态发生蛋白拥有着多种多样的生物活性,比如在早期的胚胎发生、多方位的器官形成等方面都能通过调节细胞的增殖、分化和凋亡来实现功能。通过体外和体内试验,一系列人骨形态发生蛋白已经被证实可以刺激骨形成,同时重组人骨形成蛋白也被应用。至今,已经有超过20种BMP被鉴定和表征,他们都是转化生长因子β(TGF-β)超家族的成员。其中,BMP-2具有几乎和自体骨相当的骨修复能力,被认为具有最强的骨诱导活性。Bone morphogenetic protein (BMP) is widely used mainly because it induces the formation of bone and cartilage, can be used as a therapeutic agent for the treatment of fractures and periodontal defects, and can induce bone growth around implants and artificial prostheses. Traditional gene knockout experiments have shown that bone morphogenetic proteins possess a variety of biological activities, such as early embryogenesis, multi-dimensional organ formation and other functions can be achieved by regulating cell proliferation, differentiation and apoptosis. Through in vitro and in vivo experiments, a series of human bone morphogenetic proteins have been shown to stimulate bone formation, and recombinant human bone morphogenetic proteins have also been applied. To date, more than 20 BMPs have been identified and characterized, all of which are members of the transforming growth factor beta (TGF-beta) superfamily. Among them, BMP-2 has almost the same bone repairing ability as autologous bone and is considered to have the strongest osteoinductive activity.
灭菌是BMP-2及负载BMP-2医疗器械临床使用前必需的操作。但是现行的几种常规灭菌方式都会使BMP-2失去活性。环氧乙烷可与蛋白类物质发生化学反应而使BMP-2失活;高压蒸汽灭菌使BMP-2变性而失活。Sterilization is required for the clinical use of BMP-2 and BMP-2 loaded medical devices. However, several conventional sterilization methods currently deactivate BMP-2. Ethylene oxide can chemically react with proteinaceous materials to inactivate BMP-2; autoclaving sterilizes BMP-2 and inactivates it.
辐照灭菌是通过放射性物质发出辐射线杀死大多数物质上的微生物的一种有效方法,在整个灭菌过程中,温度并不明显升高,对于热敏性化合物是很好的灭菌方式。Irradiation sterilization is an effective method for killing microorganisms on most substances by emitting radiation from radioactive materials. The temperature is not significantly increased throughout the sterilization process, and it is a good sterilization method for heat sensitive compounds.
发明内容Summary of the invention
本发明的目的在于射线辐照有效地对BMP-2灭菌同时维持其活性。It is an object of the present invention to effectively sterilize BMP-2 while maintaining its activity by radiation.
本发明的技术方案如下:The technical solution of the present invention is as follows:
本发明将BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用60Co、137Cs、192Ir源射线辐照,设定剂量为0.01-100kGy,优选设定剂量为15-50kGy;实现对BMP-2的辐照过程。The invention adds the BMP-2 solution into the centrifuge tube, seals it with a sealing film, puts it into a thermos flask, fills it with ice, irradiates with 60 Co, 137 Cs, 192 Ir source rays, and sets the dose to be 0.01-100 kGy. Preferably, the dosage is set to 15-50 kGy; the irradiation process to BMP-2 is achieved.
然后将细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2 组、辐照的BMP-2组,细胞培养7天后检测每个孔ALP含量。通过ALP含量的高低来确定BMP-2的活性高低,实现对BMP-2活性的检测。The cells were then routinely cultured in DF12 complete medium to establish unirradiated BMP-2. The group and irradiated BMP-2 group were tested for ALP content in each well after 7 days of cell culture. The activity of BMP-2 was determined by the level of ALP, and the detection of BMP-2 activity was achieved.
本发明检测BMP-2活性的原理是ALP是细胞向成骨细胞分化的重要指标,BMP-2活性高,细胞向成骨细胞分化的趋势明显,则ALP表达量高,通过ALP的含量高低可以检测BMP-2活性的高低。The principle of detecting BMP-2 activity in the present invention is that ALP is an important index for cell differentiation into osteoblasts, BMP-2 activity is high, and the tendency of cells to differentiate into osteoblasts is obvious, and the ALP expression level is high, and the content of ALP can be high or low. The level of BMP-2 activity was measured.
本发明的优点在于有效解决了BMP-2辐照灭菌过程中失活问题,提高了其应用前景。The invention has the advantages that the problem of deactivation in the process of BMP-2 irradiation sterilization is effectively solved, and the application prospect thereof is improved.
图1:60Co射线25kGy辐照后细胞中ALP含量变化;Figure 1: Changes in ALP content in cells after 60 Co-irradiation at 25 kGy;
图2:60Co射线50kGy辐照后细胞中ALP含量变化;Figure 2: Changes in ALP content in cells after 60 CoG irradiation at 50 kGy;
图3:60Co射线35kGy辐照后细胞中ALP含量变化。Figure 3: Changes in ALP content in cells after 60 Co-ray irradiation at 35 kGy.
具体实施方法Specific implementation method
下面通过例子对本发明专利进行进一步的阐述。The invention patent is further illustrated by way of example below.
实施例1:Example 1:
1.准备BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用60Co源射线辐照,设定剂量为0.01kGy。1. Prepare the BMP-2 solution into the centrifuge tube, seal it with a sealing film, place it in a thermos flask, fill it with ice, and irradiate with 60 Co source radiation to set the dose to 0.01kGy.
2.脐带血间充质干细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2组、辐照的BMP-2组。细胞培养7天后检测每个孔ALP含量。2. Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
3.通过对ALP含量的分析,我们可以看到,BMP-2辐照之后,其ALP表达量与未辐照的BMP-2的ALP表达量相近,并没有显著性差异,从而证明辐照之后BMP-2活性得到维持。3. By analyzing the ALP content, we can see that after BMP-2 irradiation, the ALP expression level is similar to that of unirradiated BMP-2, and there is no significant difference, which proves that after irradiation BMP-2 activity is maintained.
实施例2:Example 2:
1.准备BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用137Cs源射线辐照,设定剂量为0.01kGy。1. Prepare BMP-2 solution into the centrifuge tube, seal it with sealing film, put it into the thermos bottle, fill it with ice, irradiate with 137 Cs source radiation, set the dose to 0.01kGy.
2.脐带血间充质干细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2组、辐照的BMP-2组。细胞培养7天后检测每个孔ALP含量。2. Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
3.通过对ALP含量的分析,我们可以看到,BMP-2辐照之后,其ALP表 达量与未辐照的BMP-2的ALP表达量相近,并没有显著性差异,从而证明辐照之后BMP-2活性得到维持。3. By analyzing the ALP content, we can see that after BMP-2 irradiation, its ALP table The amount of ALP expression was similar to that of unirradiated BMP-2, and there was no significant difference, which proved that BMP-2 activity was maintained after irradiation.
实施例3:Example 3:
1.准备BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用192Ir源射线辐照,设定剂量为0.01kGy。1. Prepare the BMP-2 solution into the centrifuge tube, seal it with a sealing film, place it in a thermos flask, fill it with ice, and irradiate with 192 Ir source radiation to set the dose to 0.01kGy.
2.脐带血间充质干细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2组、辐照的BMP-2组。细胞培养7天后检测每个孔ALP含量。2. Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
3.通过对ALP含量的分析,我们可以看到,BMP-2辐照之后,其ALP表达量与未辐照的BMP-2的ALP表达量相近,并没有显著性差异,从而证明辐照之后BMP-2活性得到维持。3. By analyzing the ALP content, we can see that after BMP-2 irradiation, the ALP expression level is similar to that of unirradiated BMP-2, and there is no significant difference, which proves that after irradiation BMP-2 activity is maintained.
实施例4:Example 4:
1.准备BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用60Co源射线辐照,设定剂量为100kGy。1. Prepare the BMP-2 solution into the centrifuge tube, seal it with a sealing film, place it in a thermos flask, fill it with ice, and irradiate with 60 Co source radiation to set the dose to 100kGy.
2.脐带血间充质干细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2组、辐照的BMP-2组。细胞培养7天后检测每个孔ALP含量。2. Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
3.通过对ALP含量的分析,我们可以看到,BMP-2辐照之后,其ALP表达量与未辐照的BMP-2的ALP表达量相近,并没有显著性差异,从而证明辐照之后BMP-2活性得到维持。3. By analyzing the ALP content, we can see that after BMP-2 irradiation, the ALP expression level is similar to that of unirradiated BMP-2, and there is no significant difference, which proves that after irradiation BMP-2 activity is maintained.
实施例5:Example 5:
1.准备BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用137Cs源射线辐照,设定剂量为100kGy。1. Prepare the BMP-2 solution into the centrifuge tube, seal it with a sealing film, place it in a thermos flask, fill it with ice, and irradiate with 137 Cs source radiation to set the dose to 100kGy.
2.脐带血间充质干细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2组、辐照的BMP-2组。细胞培养7天后检测每个孔ALP含量。2. Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
3.通过对ALP含量的分析,我们可以看到,BMP-2辐照之后,其ALP表达量与未辐照的BMP-2的ALP表达量相近,并没有显著性差异,从而证明辐照之后BMP-2活性得到维持。3. By analyzing the ALP content, we can see that after BMP-2 irradiation, the ALP expression level is similar to that of unirradiated BMP-2, and there is no significant difference, which proves that after irradiation BMP-2 activity is maintained.
实施例6:Example 6
1.准备BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用192Ir源射线辐照,设定剂量为100kGy。 1. Prepare the BMP-2 solution into the centrifuge tube, seal it with a sealing film, place it in a thermos flask, fill it with ice, and irradiate with 192 Ir source radiation to set the dose to 100kGy.
2.脐带血间充质干细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2组、辐照的BMP-2组。细胞培养7天后检测每个孔ALP含量。2. Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
3.通过对ALP含量的分析,我们可以看到,BMP-2辐照之后,其ALP表达量与未辐照的BMP-2的ALP表达量相近,并没有显著性差异,从而证明辐照之后BMP-2活性得到维持。3. By analyzing the ALP content, we can see that after BMP-2 irradiation, the ALP expression level is similar to that of unirradiated BMP-2, and there is no significant difference, which proves that after irradiation BMP-2 activity is maintained.
实施例7:Example 7
1.准备BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用60Co源射线辐照,设定剂量为25kGy。1. Prepare the BMP-2 solution into the centrifuge tube, seal it with a sealing film, place it in a thermos flask, fill it with ice, and irradiate with 60 Co source radiation to set the dose to 25kGy.
2.脐带血间充质干细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2组、辐照的BMP-2组。细胞培养7天后检测每个孔ALP含量。2. Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
3.通过对ALP含量的分析,我们可以看到,BMP-2辐照之后,其ALP表达量与未辐照的BMP-2的ALP表达量相近,并没有显著性差异,从而证明辐照之后BMP-2活性得到维持。实验结果如附图1所示。3. By analyzing the ALP content, we can see that after BMP-2 irradiation, the ALP expression level is similar to that of unirradiated BMP-2, and there is no significant difference, which proves that after irradiation BMP-2 activity is maintained. The experimental results are shown in Figure 1.
实施例8:Example 8
1.准备BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用60Co源射线辐照,设定剂量为50kGy。1. Prepare BMP-2 solution into the centrifuge tube, seal it with sealing film, put it into the thermos bottle, fill it with ice, irradiate with 60 Co source radiation, set the dose to 50kGy.
2.脐带血间充质干细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2组、辐照的BMP-2组。细胞培养7天后检测每个孔ALP含量。2. Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
3.通过对ALP含量的分析,我们可以看到,BMP-2辐照之后,其ALP表达量与未辐照的BMP-2的ALP表达量相近,并没有显著性差异,从而证明辐照之后BMP-2活性得到维持。实验结果如附图2所示。3. By analyzing the ALP content, we can see that after BMP-2 irradiation, the ALP expression level is similar to that of unirradiated BMP-2, and there is no significant difference, which proves that after irradiation BMP-2 activity is maintained. The experimental results are shown in Figure 2.
实施例9:Example 9
1.准备BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用60Co源射线辐照,设定剂量为35kGy。1. Prepare the BMP-2 solution into the centrifuge tube, seal it with a sealing film, place it in a thermos flask, fill it with ice, and irradiate with 60 Co source radiation to set the dose to 35kGy.
2.脐带血间充质干细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2组、辐照的BMP-2组。细胞培养7天后检测每个孔ALP含量。2. Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
3.通过对ALP含量的分析,我们可以看到,BMP-2辐照之后,其ALP表达量与未辐照的BMP-2的ALP表达量相近,并没有显著性差异,从而证明辐照之后BMP-2活性得到维持。实验结果如附图3所示。 3. By analyzing the ALP content, we can see that after BMP-2 irradiation, the ALP expression level is similar to that of unirradiated BMP-2, and there is no significant difference, which proves that after irradiation BMP-2 activity is maintained. The experimental results are shown in Figure 3.
实施例10:Example 10:
1.准备BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用137Cs源射线辐照,设定剂量为25kGy。1. Prepare the BMP-2 solution into the centrifuge tube, seal it with a sealing film, place it in a thermos flask, fill it with ice, and irradiate with 137 Cs source radiation to set the dose to 25kGy.
2.脐带血间充质干细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2组、辐照的BMP-2组。细胞培养7天后检测每个孔ALP含量。2. Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
3.通过对ALP含量的分析,我们可以看到,BMP-2辐照之后,其ALP表达量与未辐照的BMP-2的ALP表达量相近,并没有显著性差异,从而证明辐照之后BMP-2活性得到维持。3. By analyzing the ALP content, we can see that after BMP-2 irradiation, the ALP expression level is similar to that of unirradiated BMP-2, and there is no significant difference, which proves that after irradiation BMP-2 activity is maintained.
实施例11:Example 11
1.准备BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用192Ir源射线辐照,设定剂量为50kGy。1. Prepare the BMP-2 solution into the centrifuge tube, seal it with a sealing film, place it in a thermos flask, fill it with ice, and irradiate with 192 Ir source radiation to set the dose to 50kGy.
2.脐带血间充质干细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2组、辐照的BMP-2组。细胞培养7天后检测每个孔ALP含量。2. Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
3.通过对ALP含量的分析,我们可以看到,BMP-2辐照之后,其ALP表达量与未辐照的BMP-2的ALP表达量相近,并没有显著性差异,从而证明辐照之后BMP-2活性得到维持。3. By analyzing the ALP content, we can see that after BMP-2 irradiation, the ALP expression level is similar to that of unirradiated BMP-2, and there is no significant difference, which proves that after irradiation BMP-2 activity is maintained.
实施例11:Example 11
1.准备BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用192Ir源射线辐照,设定剂量为28kGy。1. Prepare the BMP-2 solution into the centrifuge tube, seal it with a sealing film, place it in a thermos flask, fill it with ice, and irradiate with 192 Ir source radiation to set the dose to 28kGy.
2.脐带血间充质干细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2组、辐照的BMP-2组。细胞培养7天后检测每个孔ALP含量。2. Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
3.通过对ALP含量的分析,我们可以看到,BMP-2辐照之后,其ALP表达量与未辐照的BMP-2的ALP表达量相近,并没有显著性差异,从而证明辐照之后BMP-2活性得到维持。3. By analyzing the ALP content, we can see that after BMP-2 irradiation, the ALP expression level is similar to that of unirradiated BMP-2, and there is no significant difference, which proves that after irradiation BMP-2 activity is maintained.
实施例12:Example 12
1.准备BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用60Co源射线辐照,设定剂量为15kGy。1. Prepare the BMP-2 solution into the centrifuge tube, seal it with a sealing film, place it in a thermos flask, fill it with ice, and irradiate with 60 Co source radiation to set the dose to 15kGy.
2.脐带血间充质干细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2组、辐照的BMP-2组。细胞培养7天后检测每个孔ALP含量。 2. Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
3.通过对ALP含量的分析,我们可以看到,BMP-2辐照之后,其ALP表达量与未辐照的BMP-2的ALP表达量相近,并没有显著性差异,从而证明辐照之后BMP-2活性得到维持。3. By analyzing the ALP content, we can see that after BMP-2 irradiation, the ALP expression level is similar to that of unirradiated BMP-2, and there is no significant difference, which proves that after irradiation BMP-2 activity is maintained.
实施例13:Example 13
1.准备BMP-2溶液加入离心管中,用封口膜封好,放入保温瓶中,装满冰,用137Cs源射线辐照,设定剂量为15kGy。1. Prepare the BMP-2 solution into the centrifuge tube, seal it with a sealing film, place it in a thermos flask, fill it with ice, and irradiate with 137 Cs source radiation to set the dose to 15kGy.
2.脐带血间充质干细胞在DF12完全培养液中常规培养,分别设立未辐照的BMP-2组、辐照的BMP-2组。细胞培养7天后检测每个孔ALP含量。2. Umbilical cord blood mesenchymal stem cells were routinely cultured in DF12 complete medium, and unirradiated BMP-2 group and irradiated BMP-2 group were established. The ALP content of each well was measured after 7 days of cell culture.
3.通过对ALP含量的分析,我们可以看到,BMP-2辐照之后,其ALP表达量与未辐照的BMP-2的ALP表达量相近,并没有显著性差异,从而证明辐照之后BMP-2活性得到维持。 3. By analyzing the ALP content, we can see that after BMP-2 irradiation, the ALP expression level is similar to that of unirradiated BMP-2, and there is no significant difference, which proves that after irradiation BMP-2 activity is maintained.
Claims (2)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410583411.8A CN104307005A (en) | 2014-10-27 | 2014-10-27 | Method for maintaining activity of bone morphogenetic protein-2 under irradiation sterilization condition |
| CN201410583411.8 | 2014-10-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2016065684A1 true WO2016065684A1 (en) | 2016-05-06 |
Family
ID=52362406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2014/092094 Ceased WO2016065684A1 (en) | 2014-10-27 | 2014-11-24 | Method for maintaining bone morphogenetic protein-2 activity under the irradiation sterilization conditions |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN104307005A (en) |
| WO (1) | WO2016065684A1 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000033893A1 (en) * | 1998-12-07 | 2000-06-15 | Johnson & Johnson Medical Limited | Sterile complex of therapeutic peptide bond to a polysaccharide |
| WO2006007780A1 (en) * | 2004-07-22 | 2006-01-26 | Fang Xu | Injectable bone-repairing bioactive material capable of forming gel and its preparation method |
| CN103480040A (en) * | 2013-09-27 | 2014-01-01 | 中国人民解放军第三军医大学第一附属医院 | Bone matrix material containing various proteins secreted by umbilical cord mesenchymal stem cells and preparation method thereof |
-
2014
- 2014-10-27 CN CN201410583411.8A patent/CN104307005A/en active Pending
- 2014-11-24 WO PCT/CN2014/092094 patent/WO2016065684A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000033893A1 (en) * | 1998-12-07 | 2000-06-15 | Johnson & Johnson Medical Limited | Sterile complex of therapeutic peptide bond to a polysaccharide |
| WO2006007780A1 (en) * | 2004-07-22 | 2006-01-26 | Fang Xu | Injectable bone-repairing bioactive material capable of forming gel and its preparation method |
| CN103480040A (en) * | 2013-09-27 | 2014-01-01 | 中国人民解放军第三军医大学第一附属医院 | Bone matrix material containing various proteins secreted by umbilical cord mesenchymal stem cells and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| LI, YIUSHEN: "The Effects of Radiation on rhBMP-2 Bone Induction Activity", CHINESE JOURNAL OF ORTHOPAEDICS, vol. 25, no. 3, 31 March 2005 (2005-03-31), pages 176 - 180 * |
| ZUO, AIJUN: "Effect of rhBMP-2 on the Osteogenesis of Osteoblast Compounded Chitosan", CHINA BIOTECHNOLOGY, vol. 26, no. 5, 31 December 2006 (2006-12-31), pages 33 - 37 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104307005A (en) | 2015-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zheng et al. | Protein interactions with bioactive glass surfaces: a review | |
| Decambron et al. | Low‐dose BMP‐2 and MSC dual delivery onto coral scaffold for critical‐size bone defect regeneration in sheep | |
| Ismail et al. | Mesenchymal stem cell implantation in atrophic nonunion of the long bones: a translational study | |
| White et al. | The impact of sterilization upon extracellular matrix hydrogel structure and function | |
| CN205268655U (en) | Multiple degassing unit of medical care utensil for surgery | |
| CN112316166B (en) | A riboflavin photochemical inactivation method for pathogens in biological fluid samples | |
| Cruz et al. | Marine collagen scaffolds and photobiomodulation on bone healing process in a model of calvaria defects | |
| US12270045B2 (en) | Method for preparing an irradiated platelet lysate | |
| Gallego et al. | Repair of segmental mandibular bone defects in sheep using bone marrow stromal cells and autologous serum scaffold: a pilot study | |
| Westhauser et al. | Gelatin coating increases in vivo bone formation capacity of three‐dimensional 45S5 bioactive glass‐based crystalline scaffolds | |
| RU2526429C1 (en) | Method of manufacturing bone implants | |
| Dai et al. | Time‐Dependent Electrical Active and Ultrasound‐Responsive Calcium Titanate Implant Coating with Immunomodulation, Osteogenesis, and Customized Antibacterial Activity | |
| RU2524618C1 (en) | Combined bone allograft and method for preparing it | |
| US11577062B2 (en) | Systems and methods for in-situ, bottom-up tissue generation | |
| WO2016065684A1 (en) | Method for maintaining bone morphogenetic protein-2 activity under the irradiation sterilization conditions | |
| Lammens et al. | The Pentaconcept in skeletal tissue engineering. A combined approach for the repair of bone defects | |
| RU86455U1 (en) | BIO ENGINEERING DESIGN | |
| CN114832156B (en) | Novel medical and cosmetic shaping filler modified L-polylactic acid gel | |
| CN104353092B (en) | Sterilization method for improving synostosis of SLA implant | |
| Turner et al. | Human NELL1 protein augments constructive tissue remodeling with biologic scaffolds | |
| Hilmy et al. | Experiences using IAEA Code of practice for radiation sterilization of tissue allografts: validation and routine control | |
| CN101735984B (en) | A Simple Method for Inoculating Cells with Tissue Engineering Scaffold Materials | |
| Saeed et al. | In vitro evaluation of decontamination effects on mechanical properties of fibrin membrane | |
| CN104874023A (en) | Production method of finished-product tissue engineered bone | |
| US20150147408A1 (en) | Method validation unit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14904763 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 14904763 Country of ref document: EP Kind code of ref document: A1 |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 14904763 Country of ref document: EP Kind code of ref document: A1 |
|
| 32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 17.01.2018) |